McKesson EVP, CIO and CTO Francisco Fraga sells $797,128 in stock

Francisco Fraga, Executive Vice President, Chief Information Officer, and Chief Technology Officer at MCKESSON CORP (NYSE:MCK), recently disposed of shares in the company.

On October 15, 2026, Mr. Fraga sold 800.491 shares of McKesson common stock. The transaction was valued at $797,128, with shares sold at a price of $995.80 each. The sale occurred as the stock trades near its 52-week high of $1,015, reflecting a strong year with returns of nearly 29% over the past twelve months.

Following this transaction, Mr. Fraga now directly holds 5,423.496 shares of McKesson common stock. This total includes 6.78 shares acquired on June 30, 2026, and 6.79 shares acquired on September 30, 2026, through the Fidelity Dividend Reinvestment Plan. The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was previously adopted on March 10, 2026. According to InvestingPro analysis, McKesson appears undervalued at current levels, with 18 additional ProTips available to subscribers.

In other recent news, McKesson Corporation reported better-than-expected first-quarter fiscal 2027 results, with adjusted earnings per share reaching $9.93, surpassing Wall Street’s estimate of $9.64. Revenue also exceeded forecasts, coming in at $105.38 billion compared to the anticipated $103.82 billion. Following these results, McKesson raised its full-year earnings outlook. Additionally, McKesson announced a definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion, which will enhance its clinical research and biopharma commercialization services. This acquisition will be integrated into McKesson’s Oncology & Multispecialty segment.

In related developments, Wells Fargo raised its price target for McKesson to $933 from $812 while maintaining an Equal Weight rating, citing increased earnings estimates for the coming fiscal years. The firm projected adjusted earnings per share of $44.60, $49.94, and $56.00 for fiscal years 2027, 2028, and 2029, respectively, indicating significant year-over-year growth. These recent developments highlight McKesson’s strategic moves and positive financial performance.